•  
  •  
  •  
  •  

2026-07-24 19:53:41

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Takyon Networks Ltd receives order worth Rs. 1.43 crore
  • Rolcon Engineering Company Reports Q1 FY27 Results; Net Profit at ₹76.35 Lakhs, Total Income Reaches ₹1,279 Lakhs
  • Ratnaveer Precision Engineering Reports Strong Q1 Performance as Net Profit Rises to ₹182.37 Lakhs
  • REC Limited Reports Q1 FY27 Consolidated Net Profit of ₹4,193 Crore; Total Comprehensive Income Surges to ₹7,440 Crore
  • Bank of India Surge: Q1 FY27 Net Profit Jumps 36% to ₹3,068 Crore as Asset Quality Reaches Record Highs

Keywords Selected:  EDQM

Stock Report

  • Auro Laboratories Ltd receives Certification of Substances Department from EDQM
  • IOL Chemicals and Pharmaceuticals Ltd granted EDQM CEP for Metformin Hydrochloride Process-II
  • Smruthi Organics Ltd receives Attestation of Inspection from EDQM
  • IOL Chemicals and Pharmaceuticals Ltd gets EDQM's CEP for API Clopidogrel Besilate
  • EDQM issues CEP Certificate for MINOXIDIL to IOL Chemicals & Pharmaceuticals Ltd
  • Anuh Pharma Ltd granted CEP from EDQM for Sulfadimethoxine
  • IOL Chemicals and Pharmaceuticals Ltd receives EDQM Ceritificate of Suitability for Sitagliptin Phosphate Monohydrate
  • IOL Chemicals and Pharmaceuticals Ltd receives EDQM certificate for Pantoprazole Sodium Sesquihydrate Process-III
  • Fermenta announces Granting of CEP by EDQM for VITADEE™ 100 SD, Enabling Accelerated Global Growth
  • Sigachi Industries Ltd receives CEP for Metformin Hydrochloride from EDQM
  • Nectar Lifesciences Limited receives 7 observations from EDQM for API facility
  • EDQM issues CEP Certificate for IOL Chemicals and Pharmaceuticals Ltd's API Quetiapine Fumarate
  • Shilpa Pharma Lifesciences Limited, Received CEP from EDQM for API, Teriflunomide
  • EDQM issued CEP Certificate for MESALAZINE
  • Sigachi Industries Ltd arm receives CEP from EDQM for Propafenone Hydrochloride
  • Shilpa Pharma Lifesciences Limited, received CEP from EDQM for API, Nifedipine
  • Shilpa Pharma Lifesciences Limited, Received CEP from EDQM for API, Octreotide
  • Shilpa Pharma Lifesciences Limited, received CEP from EDQM for API, Desmopressin
  • Anuh Pharma Ltd received EDQM approval for CEP of Allopurinol API
  • Wanbury Ltd received CEP approval from EDQM for the launch of its new product, Dextromethorphan API
  • Shilpa Pharma Lifesciences Ltd received CEP from EDQM for API, Ursodeoxycholic Acid
  • EDQM issues CEP certificate to IOL Chemicals and Pharmaceuticals Ltd for Valsartan
  • NGL Fine-Chem Limited receives CEP from EDQM for TRICLABENDAZOLE
  • IOL Chemicals and Pharmaceuticals Ltd receives EDQM CEP certificate for Allopurinol

Latest Post

  • Takyon Networks Ltd receives order worth Rs. 1.43 crore
  • Rolcon Engineering Company Reports Q1 FY27 Results; Net Profit at ₹76.35 Lakhs, Total Income Reaches ₹1,279 Lakhs
  • Ratnaveer Precision Engineering Reports Strong Q1 Performance as Net Profit Rises to ₹182.37 Lakhs
  • REC Limited Reports Q1 FY27 Consolidated Net Profit of ₹4,193 Crore; Total Comprehensive Income Surges to ₹7,440 Crore
  • Bank of India Surge: Q1 FY27 Net Profit Jumps 36% to ₹3,068 Crore as Asset Quality Reaches Record Highs


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025